Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac myosin binding protein C correlate with cardiac troponin I during an exercise training program in patients with HFrEF.

ESC heart failure·2025
Same author

Comparative electroencephalography analysis: Marathon runners during tapering versus sedentary controls reveals no significant differences.

Brain and behavior·2024
Same author

Study protocol of a cluster-randomised controlled trial assessing a multimodal machine-based exercise training programme in senior care facilities over 6 months - the bestform study (best function of range of motion).

BMC geriatrics·2023
Same author

Capsular inflammation after immediate breast reconstruction - Gene expression patterns and inflammatory cell infiltration in irradiated and non-irradiated breasts.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2022
Same author

Cardiopulmonary exercise testing excludes significant disease in patients recovering from COVID-19.

BMJ military health·2022
Same author

Progressive machine-based resistance training for prevention and treatment of sarcopenia in the oldest old: A systematic review and meta-analysis.

Experimental gerontology·2022

Related Experiment Video

Updated: May 24, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

[Diabetes and heart failure: a practically oriented critical appraisal].

M Halle1, A K Gitt, M Hanefeld

  • 1Zentrum für Prävention und Sportmedizin an der TU München.

Deutsche Medizinische Wochenschrift (1946)
|February 23, 2012
PubMed
Summary

Type 2 diabetes patients face higher heart failure risks. Differentiating systolic and diastolic heart failure and tailoring antidiabetic treatments are crucial for better patient outcomes.

Related Experiment Videos

Last Updated: May 24, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Diseases

Context:

  • Type 2 diabetes mellitus (T2DM) significantly increases the risk of developing heart failure (HF).
  • HF in T2DM patients presents as either heart failure with reduced ejection fraction (HFREF) or heart failure with preserved ejection fraction (HFPEF).
  • The distinct pathophysiology of HFREF and HFPEF in T2DM involves myocardial metabolism and coronary circulation impairments.

Purpose:

  • To differentiate between HFREF and HFPEF in diabetic patients using echocardiography and tissue Doppler imaging.
  • To highlight the critical need for specific management strategies for heart failure in diabetic patients, considering prognosis and drug interactions.
  • To emphasize the importance of optimized glycemic control and cardiovascular risk factor management for both HFREF and HFPEF.

Summary:

  • Diabetic patients with heart failure require precise diagnosis of systolic (HFREF) versus diastolic (HFPEF) dysfunction.
  • Management must address the unique pathophysiology and clinical implications of each HF type in diabetes.
  • Optimized blood glucose lowering and cardiovascular risk factor management are essential, with tailored antidiabetic medication selection being paramount.

Impact:

  • This approach aims to improve clinical outcomes for diabetic patients suffering from heart failure.
  • Highlights the need for future interventional studies focusing on specific HF entities in T2DM.
  • Informs clinical practice regarding the careful selection and adaptation of antidiabetic therapies in heart failure patients.